Systemic Chemotherapy for Progression of Brain Metastases in Extensive-Stage Small Cell Lung Cancer
Lung cancer is the most common cause of cancer related mortality in men and women. Approximately 15% of lung cancers are small cell type. Chemotherapy and radiation are the mainstay treatments. Currently, the standard chemotherapy regimen includes platinum/etoposide. For extensive small cell lung ca...
Main Authors: | Nagla Abdel Karim, Ananta Bhatt, Lauren Chiec, Richard Curry |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2015/620582 |
Similar Items
-
Progress of Treatments in Non-small Cell Lung Cancer with Brain Metastases
by: Chunhua MA, et al.
Published: (2012-05-01) -
Male Pelvic Squamous Cell Carcinoma of Unknown Primary Origin
by: Lauren Chiec, et al.
Published: (2014-01-01) -
Brain Radiotherapy Combined with Sequential Chemotherapy in Non-Small-Cell Lung Cancer Patients with Brain Metastases
by: Likun CHEN, et al.
Published: (2009-08-01) -
Risk factors for brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, radiotherapy and chemotherapy
by: Petrović Marina, et al.
Published: (2011-01-01) -
Research Progress in the Treatment of Brain Metastases
from Non-small Cell Lung Cancer
by: Xue HAN, et al.
Published: (2020-12-01)